Page last updated: 2024-10-21

pk 11195 and B16 Melanoma

pk 11195 has been researched along with B16 Melanoma in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research Excerpts

ExcerptRelevanceReference
"In this study, we evaluated the effect of several ligands active at the central-type and peripheral-type benzodiazepine receptor (BzR) (clonazepam, diazepam, PK11195 and Ro5-4864) on the growth and differentiation of B16 melanoma cells."3.70Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. ( Beery, E; Brenner, S; Gavish, M; Landau, M; Landau, O; Nordenberg, J; Wasseman, L; Weizman, A; Zoref-Shani, E, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Landau, M1
Weizman, A1
Zoref-Shani, E1
Beery, E1
Wasseman, L1
Landau, O1
Gavish, M1
Brenner, S1
Nordenberg, J1

Other Studies

1 other study available for pk 11195 and B16 Melanoma

ArticleYear
Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells.
    Biochemical pharmacology, 1998, Oct-15, Volume: 56, Issue:8

    Topics: Animals; Antineoplastic Agents; Benzodiazepinones; Cell Cycle; Cell Differentiation; Cell Division;

1998